{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:36:02Z","timestamp":1793918162958,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The obesity paradox has been observed in patients with cardiovascular disease. The goal of this study was to evaluate if obesity has a protective effect in patients presenting with non-ST-elevation myocardial infarction (NSTEMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using a large Nationwide Inpatient Sample (NIS) database, we evaluated mortality in patients with NSTEMI based on weight categories in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 3,597,279 NSTEMI patients were found in the database over the age of 18 years. We found that overweight and obesity, followed by morbid obesity, had the lowest mortality using univariate (overweight mortality of 3.2% vs. obesity mortality of 3.78% vs. morbid obesity mortality of 5.69% vs. 7.8% of normal weights), whereas cachexia was associated with the highest mortality in univariate analysis (cachexia 21.82%). Using multivariate analysis adjusting for baseline characteristics and comorbidities, those relations remained unchanged (cachexia Multivariate Odds ratio (MVOR): 2.56, confidence interval [CI]: 2.41\u20132.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001; overweight MVOR: 0.49, CI: 041\u20130.59,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001; obesity MVOR: 0.6, CI: 0.58\u20130.63,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001; and morbid obesity MVOR: 0.94, CI: 0.9\u20130.98,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We observe an obesity paradox in patients with NSTEMI, showing that overweight, followed by obesity and morbid obesity, have the lowest mortality, with cachexia having the highest mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/heartviews.heartviews_98_25","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:00:33Z","timestamp":1763730033000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Obesity Paradox Occurs in Non-ST-elevation Myocardial Infarction for Overweight and Obesity but Not for Morbid Obesity"],"prefix":"10.4103","volume":"26","author":[{"given":"Mehrtash","family":"Hashemzadeh","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Arizona, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Parsa","family":"Abhari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Movahed","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Arizona, Phoenix, AZ, USA"},{"name":"Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. State-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/VHRM.S168946","article-title":"Obesity paradox in cardiovascular disease: Where do we stand?","volume":"15","author":"Carbone","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pcad.2020.09.005","article-title":"Implications of obesity across the heart failure continuum","volume":"63","author":"Elagizi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrcardio.2017.108","article-title":"Management of cardiovascular diseases in patients with obesity","volume":"15","author":"Lavie","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: Mechanisms and therapies","volume":"14","author":"von Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: Facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","article-title":"Mechanisms of cachexia in chronic disease states","volume":"350","author":"Yoshida","year":"2015","journal-title":"Am J Med Sci"},{"key":"R10-20260420","first-page":"2019","article-title":"Cardiac obesity and cardiac cachexia: Is there a pathophysiological link?","author":"Selthofer-Relati\u0107","year":"2019","journal-title":"J Obes"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.amjcard.2024.08.016","article-title":"Impact of frailty on outcome of older patients with non-ST elevation acute myocardial infarction who undergo percutaneous coronary intervention","volume":"230","author":"Mele","year":"2024","journal-title":"Am J Cardiol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCOUTCOMES.111.961375","article-title":"Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization","volume":"4","author":"Singh","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjcard.2008.10.027","article-title":"Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry)","volume":"103","author":"Byrne","year":"2009","journal-title":"Am J Cardiol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjcard.2004.01.065","article-title":"Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry)","volume":"93","author":"Minutello","year":"2004","journal-title":"Am J Cardiol"},{"key":"R15-20260420","first-page":"74","article-title":"Cardiac cachexia: Perspectives for prevention and treatment","volume":"108","author":"Okoshi","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/cfr.2021.29","article-title":"The impact of frailty and comorbidities on heart failure outcomes","volume":"8","author":"Salmon","year":"2022","journal-title":"Card Fail Rev"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/cells11061039","article-title":"Interconnection between cardiac cachexia and heart failure-protective role of cardiac obesity","volume":"11","author":"Soto","year":"2022","journal-title":"Cells"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3390\/jcm13195897","article-title":"In patients presenting with an ST-elevation myocardial infarction, overweight and obese patients have the lowest inpatient mortality whereas cachexia patients have the highest inpatient mortality followed by patients with morbid obesity","volume":"13","author":"Movahed","year":"2024","journal-title":"J Clin Med"},{"key":"R19-20260420","first-page":"200230","article-title":"Low body mass index is associated with adverse cardiovascular outcomes following PCI in India: ACC\u2013NCDR registry","volume":"20","author":"Gupta","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0002-9149(96)00386-4","article-title":"Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention","volume":"78","author":"Ellis","year":"1996","journal-title":"Am J Cardiol"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"567","DOI":"10.14744\/nci.2023.87259","article-title":"Body fat percentage and infarct size in patients with non-ST segment elevation myocardial infarction","volume":"10","author":"Sungur","year":"2023","journal-title":"North Clin Istanb"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/eurheartj\/ehm220","article-title":"The impact of obesity on mortality in UA\/non-ST-segment elevation myocardial infarction","volume":"28","author":"Buettner","year":"2007","journal-title":"Eur Heart J"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCOUTCOMES.113.000421","article-title":"Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: Results from the CRUSADE registry","volume":"7","author":"O\u2019Brien","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00134-011-2321-2","article-title":"The obesity paradox in surgical intensive care unit patients","volume":"37","author":"Hutagalung","year":"2011","journal-title":"Intensive Care Med"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1378\/chest.123.4.1202","article-title":"Impact of body mass index on outcomes following critical care","volume":"123","author":"Tremblay","year":"2003","journal-title":"Chest"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.amjmed.2010.02.016","article-title":"Paradoxical preservation of vascular function in severe obesity","volume":"123","author":"Biasucci","year":"2010","journal-title":"Am J Med"}],"container-title":["Heart Views"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/heartviews.heartviews_98_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:13Z","timestamp":1787067913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/heartviews.heartviews_98_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/heartviews.heartviews_98_25","relation":{},"ISSN":["1995-705X","0976-5123"],"issn-type":[{"value":"1995-705X","type":"print"},{"value":"0976-5123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}